MASIMO CORPORATION (NASDAQ:MASI) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07(d) of Form 8-K, the Companys decision as to how
frequently the Company will conduct future stockholder advisory
votes regarding named executive officer compensation. Except as
set forth herein, no modifications have been made to the Original
8-K.
|
Item 5.07.
|
Submission of Matters to a Vote of Security Holders
|
among other matters, an advisory proposal concerning the
frequency of future advisory votes on named executive officer
compensation. As reported in the Original 8-K, the advisory vote
was in favor of annual frequency. In light of the Companys prior
practice of annual advisory votes on named executive officer
compensation and the vote of the stockholders, the Board of
Directors approved this shareholder advisory recommendation on
June 27, 2017, and the Company will continue the practice of
holding the stockholder advisory votes regarding named executive
officer compensation annually.
About MASIMO CORPORATION (NASDAQ:MASI)
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. The Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. It has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows over 200 patients to be monitored simultaneously and remotely through a personal computer (PC)-based viewing station or by care providers through their voice-over-Internet Protocol (IP) phones.